IDEAYA Biosciences, Inc.

Annual Trend FY 2010 FY 2011 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $2.2m $7.7m $20.5m $34.1m $72.0m $92.0m $68.6m $157.0m $84.4m $112.8m
Prepaid Expense and Other Assets, Current $706k $2.7m $3.1m $3.1m $5.4m $7.5m $13.4m $21.4m
Accounts receivable $1.8m $1.9m $1.9m $1.1m $211k $18k $3k
Prepaid expenses and other current assets $706k $2.7m $3.1m $3.1m $5.4m $7.5m $13.4m $21.4m
Restricted Cash, Current $0 $707k
Inventory $1.4m $1.2m
Cash Cash Equivalents And Short Term Investments $364.8m $525.1m $676.3m $639.4m
Other Short Term Investments $296.2m $368.1m $591.9m $526.6m
Assets, Current $90.7m $101.7m $288.6m $251.0m $370.5m $532.6m $689.7m $666.7m
Total current assets $7.7m $18.9m $90.7m $101.7m $288.6m $251.0m $370.5m $532.6m $689.7m $666.7m
Property, Plant and Equipment, Net $1.6m $4.8m $5.2m $4.6m $4.3m $4.8m $6.5m $6.2m $9.0m $8.2m
Intangible Assets $287k $838k
Operating Lease, Right-of-Use Asset $5.1m $5.2m $3.9m $2.5m $2.2m $18.8m $23.1m
Other Assets, Noncurrent $46k $16k $82k $291k $99k $25k
Right-of-use assets $5.1m $5.2m $3.9m $2.5m $2.2m $18.8m $23.1m
Short-term marketable securities $69.5m $64.9m $211.5m $154.7m $296.2m $368.1m $591.9m $526.6m
Contract assets $0 $6.0m
Restricted cash $106k $106k $106k $106k $106k $757k $805k $1.0m
Long-term marketable securities $1.5m $0 $121.3m $8.3m $107.5m $405.8m $410.3m
Other non-current assets $0 $328k $46k $16k $82k $291k $99k $25k $805k $1.0m
Contract liability $27.6m $29.0m $8.6m
Operating lease liabilities, current $1.1m $1.5m $1.7m $1.9m $1.7m $298k $339k
Long-term contract liability $56.2m $31.2m $5.2m
Long-term operating lease liabilities $5.6m $5.2m $3.5m $1.6m $1.1m $18.9m $27.6m
Other Non-Operating Current Assets $2.0m $239k
Deferred Tax Assets, Current $18k $46k
Other Non-Operating Non-Current Assets $975k $0
Other Current Liabilities $3k $0
Warranty and Other Provisions $73k $356k
Statutory reserve $373k $373k
Accumulated Depreciation ($7.6m) ($9.6m) ($11.7m) ($14.3m)
Available For Sale Securities $8.3m $107.5m $405.8m $410.3m
Capital Lease Obligations $3.5m $2.9m $19.2m $27.9m
Current Accrued Expenses $17.0m $18.8m $30.4m $40.9m
Current Capital Lease Obligation $1.9m $1.7m $298k $339k
Current Debt And Capital Lease Obligation $1.9m $1.7m $298k $339k
Current Deferred Liabilities $29.0m $8.6m $0
Gross PPE $16.5m $18.0m $39.5m $45.5m
Invested Capital $349.5m $621.1m $1.1b $1.0b
Investmentin Financial Assets $8.3m $107.5m $405.8m $410.3m
Investments And Advances $8.3m $107.5m $405.8m $410.3m
Leases $3.3m $3.3m $4.9m $5.1m
Long Term Capital Lease Obligation $1.6m $1.1m $18.9m $27.6m
Machinery Furniture Equipment $998k $999k $2.3m $2.3m
Net PPE $9.0m $8.4m $27.7m $31.3m
Net Tangible Assets $349.5m $621.1m $1.1b $1.0b
Non Current Deferred Liabilities $31.2m $5.2m $0
Ordinary Shares Number $48.2m $65.0m $86.5m $87.8m
Other Equity Adjustments ($2.9m) $562k $812k $2.3m
Other Properties $12.2m $13.7m $32.3m $38.1m
Properties $0 $0 $0 $0
Share Issued $48.2m $65.0m $86.5m $87.8m
Tangible Book Value $349.5m $621.1m $1.1b $1.0b
Working Capital $338.7m $505.5m $643.6m $607.9m
Accrued Liabilities, Current $3.6m $5.0m $8.5m $12.3m $17.0m $18.8m $30.4m $40.9m
Total stockholders’ equity $8.2m $15.9m ($48.9m) $100.4m $198.3m $301.5m $349.5m $621.1m $1.1b $1.0b
Total equity $10.3m $15.9m
Total Capitalization $349.5m $621.1m $1.1b $1.0b
Total Debt $3.5m $2.9m $19.2m $27.9m
Total Non Current Assets $17.5m $116.7m $434.4m $442.6m
Assets $13.3m $24.9m $96.5m $113.0m $298.3m $381.3m $388.0m $649.3m $1.1b $1.1b
LIABILITIES AND EQUITY
Total liabilities and stockholders’ equity $13.3m $24.9m $96.5m $113.0m $298.3m $381.3m $388.0m $649.3m $1.1b $1.1b
Current liabilities:
Operating Lease, Liability, Current $1.1m $1.5m $1.7m $1.9m $1.7m $298k $339k
Accounts Payable, Current $605k $785k $1.4m $709k $953k $2.1m $4.3m $6.6m $15.4m $17.6m
Operating Lease, Liability, Noncurrent $5.6m $5.2m $3.5m $1.6m $1.1m $18.9m $27.6m
Accrued Income Taxes $700k $1.2m
Current Portion of Long-Term Debt $906k $785k
Current Deferred Revenue $29.0m $8.6m $0
Payables And Accrued Expenses $21.3m $25.4m $45.8m $58.5m
Liabilities, Current $5.4m $6.9m $38.6m $45.2m $31.7m $27.1m $46.1m $58.8m
Total current liabilities $2.4m $3.5m $5.4m $6.9m $38.6m $45.2m $31.7m $27.1m $46.1m $58.8m
Other Liabilities, Noncurrent $113k $34k $12k
Long-Term Debt $0 $4.5m
Long Term Debt And Capital Lease Obligation $1.6m $1.1m $18.9m $27.6m
Liabilities $2.9m $9.0m $7.1m $12.6m $100.0m $79.8m $38.5m $28.2m $64.9m $86.4m
Stockholders’ equity:
Common Stock, Value, Issued $2k $3k $4k $5k $7k $9k $9k
Retained Earnings (Accumulated Deficit) $5.8m $2.7m ($50.5m) ($92.5m) ($127.0m) ($176.7m) ($235.4m) ($348.4m) ($622.8m) ($736.5m)
Accumulated Other Comprehensive Income (Loss), Net of Tax $530k $551k ($31k) $65k $7k ($712k) ($2.9m) $562k $812k $2.3m
Additional Paid in Capital, Common Stock $1.6m $192.8m $325.2m $479.0m $587.7m $968.9m $1.7b $1.8b
Common stock, $0.0001 par value, 300,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 87,796,561 and 86,503,509 shares issued and outstanding as of December 31, 2025 and December 31, 2024 11k 13k 2k 3k 4k 5k 7k 9k 9k
Additional paid-in capital $1.4m $12.2m $1.6m $192.8m $325.2m $479.0m $587.7m $968.9m $1.7b $1.8b
Capital Stock $5k $7k $9k $9k
Gains Losses Not Affecting Retained Earnings ($2.9m) $562k $812k $2.3m
Preferred Stock $0 $0 $0 $0
Stockholders' Equity Attributable to Parent ($48.9m) $100.4m $198.3m $301.5m $349.5m $621.1m $1.1b $1.0b
Noncontrolling Interest $2.2m $0
Total Equity Gross Minority Interest $349.5m $621.1m $1.1b $1.0b
Total Non Current Liabilities Net Minority Interest $6.8m $1.1m $18.9m $27.6m
Liabilities and Equity $96.5m $113.0m $298.3m $381.3m $388.0m $649.3m $1.1b $1.1b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.